pindolol has been researched along with Carditis in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recovery from viral myocarditis is usually excellent and complete although it occasionally results in sudden death during its acute stage." | 1.29 | Myocardial beta-receptor and cardiac angiotensin alterations during the acute and chronic phases of viral myocarditis. ( Adachi, H; Kanda, T; Murata, K; Ohno, T; Suzuki, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanda, T | 1 |
| Adachi, H | 1 |
| Ohno, T | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
1 other study available for pindolol and Carditis
| Article | Year |
|---|---|
Myocardial beta-receptor and cardiac angiotensin alterations during the acute and chronic phases of viral myocarditis.
Topics: Angiotensin I; Angiotensin II; Animals; Cardiovirus Infections; Down-Regulation; Encephalomyocarditi | 1994 |